Steve E Braunstein
Overview
Explore the profile of Steve E Braunstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu K, Salans M, Easwaran T, Phuong C, Yeo K, Elhalawani H, et al.
J Neurooncol
. 2025 Feb;
PMID: 39998722
Purpose: We characterized the association between photon radiation dose (< 59.4 versus ≥ 59.4 Gy) and outcomes in intracranial ependymoma. We also examined factors associated with survival after relapse. Methods:...
2.
Salerno K, Tsang D, Braunstein S, Parkes J, Hiniker S, Ermoian R
Int J Radiat Oncol Biol Phys
. 2024 Sep;
120(3):615-620.
PMID: 39326944
No abstract available.
3.
Pikis S, Mantziaris G, Protopapa M, Tos S, Kowalchuk R, Ross R, et al.
J Neurooncol
. 2024 Aug;
170(1):199-208.
PMID: 39192068
Purpose: To report patient outcomes and local tumor control rates in a cohort of patients with biopsy-proven HER-2 positive breast cancer treated with stereotactic radiosurgery (SRS) for brain metastases (BM)....
4.
Pike L, Miao E, Boe L, Patil T, Imber B, Myall N, et al.
J Clin Oncol
. 2024 Jul;
42(30):3606-3617.
PMID: 39047224
Purpose: Newer-generation tyrosine kinase inhibitors (TKIs) for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor () mutations and anaplastic lymphoma kinase () rearrangements have demonstrated high CNS activity....
5.
Phuong C, Qiu B, Mueller S, Braunstein S
J Natl Cancer Cent
. 2024 Jul;
3(2):141-149.
PMID: 39035723
Modern day survivorship from childhood malignancies is estimated to be over 80%. However, central nervous system tumors remain the leading cause of cancer mortality in children and is the most...
6.
Nguyen M, Almiron Bonnin D, Mirchia K, Chen W, Goldschmidt E, Braunstein S, et al.
Neurooncol Adv
. 2024 Jul;
6(1):vdae092.
PMID: 38957162
No abstract available.
7.
Liu K, Shaaban S, Chen J, Bagatell R, Lerman B, Catalano P, et al.
Radiother Oncol
. 2024 Jun;
198:110384.
PMID: 38880415
Background: Prognosis for patients with high-risk neuroblastoma (HR-NBL) is guarded despite aggressive therapy, and few studies have characterized outcomes after radiotherapy in relation to radiation treatment fields. Methods: Multi-institutional retrospective...
8.
Mahoney M, Corrigan K, Linkowski L, Abdelaal M, Munsell M, Cruz D, et al.
Adv Radiat Oncol
. 2024 Apr;
9(6):101473.
PMID: 38681887
Purpose: Virtual radiation oncology (RO) residency interviews may impair applicant and program evaluation. Second look events (SLEs) exist; however, the frequency, nature, and implications are unknown. We surveyed applicants and...
9.
Liu S, Casey-Clyde T, Cho N, Swinderman J, Pekmezci M, Dougherty M, et al.
Nat Commun
. 2024 Jan;
15(1):476.
PMID: 38216587
Mechanisms specifying cancer cell states and response to therapy are incompletely understood. Here we show epigenetic reprogramming shapes the cellular landscape of schwannomas, the most common tumors of the peripheral...
10.
Vasudevan H, Payne E, Delley C, Liu S, Mirchia K, Sale M, et al.
Nat Commun
. 2024 Jan;
15(1):477.
PMID: 38216572
Schwann cell tumors are the most common cancers of the peripheral nervous system and can arise in patients with neurofibromatosis type-1 (NF-1) or neurofibromatosis type-2 (NF-2). Functional interactions between NF1...